Maze Therapeutics

Maze Therapeutics

Maze Therapeutics

Maze Therapeutics is a company focused on translating genetic insights into new medicines
Raised
$191M
Follow us
Alexa global traffic share
Latest funding
$191,000,000
Venture capital (Series A) - 2019
Foresite Capital ARCH Venture Partners Third Rock Ventures +3
Team Size
1–10
Employees
FinSMEs

Maze Therapeutics Raises $191M in Launch Funding